Serotonin transporter (SLC6A4) extracellular allosteric site (SERT allosteric site)

The serotonin transporter (SERT) extracellular allosteric site is a regulatory region located in the extracellular vestibule of the SLC6A4 protein, distinct from the primary orthosteric binding site (Coleman et al., 2016, Nature). This site modulates the transporter's function by influencing the binding kinetics of ligands at the orthosteric site; specifically, binding at the allosteric site can sterically hinder the dissociation of orthosteric ligands, thereby prolonging the inhibition of serotonin reuptake (Zhong et al., 2012, Journal of Biological Chemistry). This mechanism is clinically relevant in the treatment of major depressive disorder and anxiety, as it explains the high potency and sustained effect of the selective serotonin reuptake inhibitor (SSRI) escitalopram (Chen et al., 2005, Journal of Biological Chemistry). By stabilizing the transporter in an outward-facing conformation, the allosteric site provides a unique pathway for fine-tuning serotonergic signaling in the central nervous system. Research into this site has been pivotal for understanding the structural biology of the solute carrier 6 (SLC6) family and for the rational design of next-generation antidepressants (Plenge et al., 2012, British Journal of Pharmacology).

Other names

S-siteSecondary binding siteExtracellular vestibule allosteric siteSLC6A4 allosteric siteLow-affinity binding site

Allosteric modulation of the serotonin transporter (SERT) occurs when a ligand binds to the extracellular vestibule, which induces a conformational change or physical barrier that slows the dissociation of ligands from the primary orthosteric site, effectively increasing the duration of reuptake inhibition (Coleman et al., 2016, Nature; Chen et al., 2005, JBC).